Skip to main content
Signal8

Pulmatrix, Inc. (PULM)

Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments. The company's primary goal is to address significant unmet medical needs in respiratory and other diseases within the United States. Central to their approach is the innovative iSPERSE (inhaled small particles easily respirable and emitted) technology. This proprietary platform allows for the precise delivery of both small and large molecule therapeutics directly into the lungs, achieving either localized effects or systemic distribution throughout the body. Pulmatrix's development pipeline includes several key candidates: Pulmazole: An inhaled antifungal drug being developed to treat allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis. PUR1800: A narrow spectrum kinase inhibitor currently undergoing Phase 1b clinical trials for individuals suffering from stable moderate-to-severe chronic obstructive pulmonary disease (COPD). PUR3100: An iSPERSE-formulated version of dihydroergotamine, intended for the rapid relief of acute migraine attacks. The company also maintains strategic collaborations, including a licensing arrangement with RespiVert Ltd. for access to a range of kinase inhibitor drug candidates, a partnership with Cipla Technologies LLC for the development and commercialization of Pulmazole, and a collaboration and license agreement with Sensory Cloud, Inc. Established in 2003, Pulmatrix, Inc. is headquartered in Lexington, Massachusetts.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Pulmatrix, Inc. logo

Pulmatrix, Inc.

NASDAQ:PULMHealthcare
-1.06%$1.40
AH$1.40+0.00%vs close
Mkt Cap$5.11M
Float3.65M
O/S3.65M
Vol
$ Vol
RVOL
Inst Own9.1%
SI1.2%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$5.16M
Total Assets$4.14M
Free Cash Flow-$5.43M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$3.81M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
  1. 1:20Reverse split
    Mar 1, 202220 shares → 1
  2. 1:10Reverse split
    Feb 6, 201910 shares → 1
Balance Sheet Details
Assets$4.14M
Liabilities$329K
Accounts Receivable$0
Accounts Payable$272K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-03-312013-03-312012-03-31
Revenue$0$7.81M$7.3M$6.07M$5.17M$12.63M$7.91M$153K$335K$835K$1.2M$352K$653K$0
YoY Growth-7.0%20.2%17.5%-59.1%59.7%5069.9%-54.3%-59.9%-30.5%241.2%-46.1%--
Cost of Revenue$38K$7.17M$15.52M$18.24M$15.38M$0$12.85M$12.97M$10.24M$10.15M$7.19M$6.59M$8.56M$0
Gross Profit-$38K$640K-$8.22M-$12.17M-$10.21M$12.63M-$4.93M-$12.81M-$9.91M-$9.32M-$5.99M-$6.24M-$7.91M$0
Gross Margin-8.2%-112.6%-200.4%-197.6%100.0%-62.4%-8374.5%-2957.6%-1115.8%-498.4%-1772.2%-1211.5%-
Research and Development$38K$7.17M$15.52M$18.24M$15.38M$15.61M$12.85M$12.97M$10.24M$17.69M$7.19M$6.59M$8.56M$20K
Selling, General, and Administrative$5.13M$7.79M$6.52M$6.78M$6.38M$6.89M$8.49M$7.52M$7.57M$8.02M$9.63M$2.84M$3.15M$0
Other-$38K-$4.55M-$15.52M-$18.24M-$11.8M$0-$5.58M-$12.9M-$10.24M-$10.15M$213K-$6.59M-$8.56M$10K
Total Operating Expenses$5.13M$10.4M$6.52M$6.78M$9.95M$22.5M$15.76M$7.59M$7.57M$15.55M$17.03M$2.84M$3.15M$30K
Operating Income (EBIT)-$5.17M-$9.76M-$14.74M-$18.95M-$20.17M-$9.86M-$20.69M-$20.4M-$17.48M-$24.87M-$23.02M-$9.08M-$11.06M-$30K
Operating Margin--125.1%-202.0%-312.1%-390.2%-78.1%-261.6%-13333.3%-5216.4%-2978.0%-1916.6%-2578.4%-1694.0%-
Interest Expense$0$0$0$0$0$0$0$186K$643K$881K$953K$0$0$0
Interest Income$144K$467K$867K$309K$7K$82K$301K$27K$0$0$0$17K$0$0
Other Income (Expense)$7K$204K$619K$111K-$4K-$9.45M$96K-$163K-$581K-$5.94M-$3.15M-$15.07M-$2.25M$0
Income Before Tax (EBT)-$5.16M-$9.56M-$14.12M-$18.84M-$20.17M-$19.31M-$20.6M-$20.56M-$18.06M-$30.8M-$26.17M-$24.14M-$13.31M-$30K
Income Tax Expense$0$0$0$0$0$0$0$0$0-$2.96M$0$0$0$0
Net Income-$5.16M-$9.56M-$14.12M-$18.84M-$20.17M-$19.31M-$20.6M-$20.56M-$18.06M-$27.84M-$26.17M-$24.14M-$13.31M-$30K
Net Income Margin--122.5%-193.5%-310.3%-390.2%-152.8%-260.4%-13439.9%-5389.9%-3334.5%-2178.8%-6859.1%-2038.1%-
Supplementary Data
EPS-1.41-2.62-3.87-5.43-8.63-19.83-24.37-99.67-186.42-375.87-646.91-765.72-130.75-7.50
Diluted EPS-1.41-2.62-3.87-5.43-8.63-19.83-24.37-99.67-186.42-375.87-646.91-765.72-130.75-7.50
Weighted Average OS3.65M3.65M3.65M3.45M2.34M1.44M836,695206,31996,85874,07640,4494,0724,0004,000
EBITDA-$5.16M-$6.71M-$12.65M-$17.29M-$15.35M-$8.82M-$12.66M-$20.1M-$17.23M-$17.08M-$15.39M-$8.73M-$10.71M-$30K
EBITDA Margin--86.0%-173.3%-284.8%-297.0%-69.8%-160.0%-13137.3%-5143.0%-2045.7%-1281.1%-2481.3%-1640.1%-
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312015-03-312013-03-312012-03-31
Assets
Current Assets
Cash and Cash Equivalents$4.09M$9.52M$19.17M$35.63M$53.84M$31.66M$23.44M$2.56M$3.55M$4.18M$18.9M$15.57M$96K$0
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$4.09M$9.52M$19.17M$35.63M$53.84M$31.66M$23.44M$2.56M$3.55M$4.18M$18.9M$15.57M$96K$0
Accounts Receivable$0$0$928K$1.3M$67K$84K$7.2M$0$1K$206K$481K$0$0$0
Inventory$0$0$0$153K$0$667K$0$0$0$0$0$0$0$0
Other Current Assets$34K$180K$372K$166K$316K-$593K$253K$55K$71K$107K$598K$114K$1K$0
Total Current Assets$4.13M$9.92M$20.84M$38.15M$54.78M$32.54M$31.42M$3.28M$4.25M$4.76M$20.46M$15.57M$100K$0
Long-Term Assets
Property, Plant & Equipment Net$0$0$11.47M$945K$2.41M$1.85M$900K$394K$614K$786K$685K$2K$4K$0
Goodwill$0$0$0$0$0$3.58M$3.58M$10.85M$10.91M$10.91M$15.94M$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$7.53M$0$0$0
Long-Term Investments$10K$10K$1.47M$1.47M$1.63M$0$204K$204K$204K$204K$250K$0$0$0
Deferred Tax Assets$0$0$0$0$0$0-$204K-$204K-$204K-$204K-$250K$0$0$0
Other Long-Term Assets$0$13K$176K$389K$0$204K$204K$204K$204K$204K$250K$0$44K$0
Total Long-Term Assets$10K$23K$13.12M$2.81M$4.04M$5.63M$4.68M$11.44M$11.73M$11.9M$24.41M$2K$48K$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$4.14M$9.94M$33.96M$40.95M$58.82M$38.17M$36.1M$14.72M$15.98M$16.66M$44.87M$15.58M$148K$0
Liabilities
Current Liabilities
Accounts Payable$272K$809K$1.92M$1.19M$839K$851K$600K$1.18M$457K$747K$1.09M$0$0$61K
Short-Term Debt$0$0$0$0$0$0$0$0$3.22M$2.59M$1.03M$39.7M$27.56M$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$146K$0$0
Current Unearned Revenue$0$0$618K$1.34M$939K$4.17M$13.41M$67K$0$0$4K-$39.92M-$27.56M$0
Other Current Liabilities$14K$71K$877K$508K$182K$1.23M$1.95M$0$138K$842K$764K$587K-$1.05M$1K
Total Current Liabilities$329K$929K$3.91M$5.02M$4.44M$8.25M$17.2M$2.88M$5.84M$4.65M$3.6M$947K$101K$0
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$3.22M$5.69M$0$0$0
Long-Term Unearned Revenue$0$0$3.73M$4.82M$6.07M$6.17M$7.88M$0$0$0-$6.53M$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$2.96M$0$0$0
Other Long-Term Liabilities$0$67K$0$0$0$0$0$0$1K$35K$11K$0$0$0
Total Long-Term Liabilities$0$67K$12.05M$4.82M$6.93M$6.78M$7.88M$0$1K$3.25M$8.66M$0$61K$0
Other Liabilities$0$0$0$0$0$0$0-$1.18M$0$0$0$0-$61K$0
Total Liabilities$329K$996K$15.96M$9.84M$11.37M$15.03M$25.08M$2.88M$5.84M$7.9M$12.27M$947K$101K$0
Stockholders' Equity
Preferred Stock$0$0$0$0$1.08M$0$0$0$0$0$0$36.88M$46.46M$0
Common Stock$0$0$0$0$0$4K$2K$0$2K$1K$1K$465$200$0
Retained Earnings-$302.32M-$297.16M-$287.6M-$273.48M-$254.64M-$234.47M-$215.16M-$194.56M-$174M-$155.95M-$128.1M-$3.67M-$551K-$28K
Comprehensive Income & Other$0$0$0$0$0$0$0-$2.12M-$2.87M-$2.67M$0-$2K-$0$0
Other Stockholders' Equity$306.13M$306.1M$305.59M$304.58M$302.09M$257.6M$226.18M$206.41M$184.14M$164.71M$160.71M$18.3M$598K$0
Total Equity$3.81M$8.95M$18M$31.11M$47.45M$23.14M$11.02M$11.84M$10.14M$8.76M$32.61M$14.63M$47K-$28K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$4.14M$9.94M$33.96M$40.95M$58.82M$38.17M$36.1M$14.72M$15.98M$16.66M$44.87M$15.58M$148K-$28K
Supplementary Data
Total Debt$0$0$8.76M$857K$2.29M$1.74M$675K$0$3.22M$5.8M$6.72M$39.7M$27.56M$0
Net Debt-$4.09M-$9.52M-$10.42M-$34.77M-$51.55M-$29.91M-$22.77M-$2.56M-$329K$1.62M-$12.18M$24.13M$27K$0
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312015-03-312013-03-312012-03-31
Operating Activities
Net Income-$5.16M-$9.56M-$14.12M-$18.84M-$20.17M-$19.31M-$20.6M-$20.56M-$18.06M-$27.84M-$26.17M-$3.12M-$523K-$30K
Depreciation & Amortization$0$435K$1.48M$1.54M$1.24M$1.04M$765K$231K$246K$250K$232K$342K$352K$0
Deferred Income Tax$0$0$0-$4.92M$0$0$0$76K-$34K$9.69M$1.18M$0$0$0
Stock-Based Compensation$25K$511K$954K$1.11M$1.16M$1.16M$2.07M$2.97M$2.82M$4M$9.76M$1.08M$444K$0
Changes in Working Capital:
  Accounts Receivable$0$928K$370K-$1.23M$17K$7.12M-$7.2M$0$0$0$0$0$0$0
  Inventory$0$0$0$0-$2.07M-$1.13M$220K$0$0$0$0$0$0$0
  Accounts Payable-$537K-$1.11M$727K$511K-$149K$300K-$583K$726K-$290K-$346K$806K$146K$61K$0
  Other Working Capital$308K-$4.61M-$5.4M-$2.46M-$3.33M-$10.96M$21.29M-$242K$635K$717K$78K$1K$36K$0
Total Working Capital Change-$229K-$4.79M-$4.3M-$3.18M-$5.53M-$4.67M$13.73M$484K$345K$371K$884K$147K$97K$0
Other Non-Cash Items-$67K$2.69M$8K$4.92M$3.58M$9.29M$7.27M$38K$204K$295K$1.64M-$1.42M$2.37M$0
Net Cash from Operating-$5.43M-$10.72M-$15.98M-$19.36M-$19.73M-$12.48M$3.23M-$16.76M-$14.48M-$13.24M-$12.47M-$2.97M-$426K-$30K
Investing Activities
Capital Expenditures$0-$398K-$676K-$86K-$144K-$281K-$58K-$19K-$74K-$455K-$266K-$156K-$4K$0
Acquisitions$0$0$0$0$0$0$0$0$0$24K$9.67M$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0$0$0$0$0$24K$0$0$0$0
Net Cash from Investing$0-$398K-$676K-$86K-$144K-$281K-$58K-$19K-$74K-$431K$9.4M-$156K-$4K$0
Financing Activities
Debt Repaid--------$2.69M$1.05M-$11.37M---
Common Stock Issuance$0$0$53K$1.38M$37.08M$7.31M$17.55M$19.3M$16.31M$0$10M$865K$16.23M$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0-$3.2M$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0$0$0$3.4M$13.67M$160K$0$304K$0$151K$7.61M-$17.38M$0
Net Cash from Financing$0$0$53K$1.23M$43.48M$20.98M$17.7M$15.79M$13.92M-$1.05M$21.52M$18.44M$526K$30K
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$5.43M-$11.11M-$16.61M-$18.21M$23.6M$8.22M$20.88M-$987K-$632K-$14.72M$18.45M$15.47M$96K$0
Supplementary Data
Operating Cash Flow-$5.43M-$10.72M-$15.98M-$19.36M-$19.73M-$12.48M$3.23M-$16.76M-$14.48M-$13.24M-$12.47M-$2.97M-$426K-$30K
Capital Expenditure$0-$398K-$676K-$86K-$144K-$281K-$58K-$19K-$74K-$455K-$266K-$156K-$4K$0
Free Cash Flow-$5.43M-$11.11M-$16.66M-$19.44M-$19.87M-$12.76M$3.17M-$16.78M-$14.55M-$13.7M-$12.74M-$3.13M-$430K-$30K
Cash at Beginning$9.53M$20.64M$37.25M$55.47M$31.86M$23.64M$2.77M$3.55M$4.18M$18.9M$451K$96K$0$0
Cash at End$4.1M$9.53M$20.64M$37.25M$55.47M$31.86M$23.64M$2.56M$3.55M$4.18M$18.9M$15.57M$96K$0